No Data
No Data
Express News | Inovio Pharmaceuticals- Cash Projection Includes an Operational Net Cash Burn Estimate of Approximately $28 Million for the Third Quarter of 2024
Express News | Inovio Pharmaceuticals Inc - Estimates Its Cash Runway to Extend Into the Third Quarter of 2025
Inovio Pharmaceuticals | 10-Q: Quarterly report
Inovio Pharmaceuticals GAAP EPS of -$1.19 Misses by $0.09, Revenue of $0.1M Misses by $0.02M
Express News | Inovio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Inovio Pharma 2Q Loss/Shr $1.19 >INO